drugset / Trial / NCT01945788

Clinical Comparison of Efficacy and Safety of Two Teriparatide Formulations: Osteofortil and Forteo

NCT01945788

Phase 4 Unknown 110 enrolled Bio Sidus SA
RandomizedParallel-groupOpen-labelTreatment

Summary

The primary objective of this study is to compare efficacy and safety of two formulations of teriparatide 20 mcg/day plus calcium and vitamin D in postmenopausal women with osteoporosis.

Timeline

Start
2013-06
Primary completion
2014-10
Completion
2014-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Teriparatide Protein / enzyme biologic 20 ug